Serum transthyretin monomer as a possible marker of blood-to-CSF barrier disruption.
Marchi N, Fazio V, Cucullo L, Kight K, Masaryk T, Barnett G, Vogelbaum M, Kinter M, Rasmussen P, Mayberg MR, Janigro D.
Marchi N, et al. Among authors: mayberg mr.
J Neurosci. 2003 Mar 1;23(5):1949-55. doi: 10.1523/JNEUROSCI.23-05-01949.2003.
J Neurosci. 2003.
PMID: 12629200
Free PMC article.
Clinical Trial.